Mackenzie Financial Corp Neogenomics Inc Transaction History

Mackenzie Financial Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$11.67 - $20.73 $29,665 - $52,695	-2,542 Reduced 14.92%	14,498 $234,000
Q3 2023 Oct 25, 2023	BUY	$12.15 - $17.85 $207,036 - $304,164	17,040 New	17,040 $209,000
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $76,277 - $221,487	-6,278 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $13,537 - $21,529	-444 Reduced 6.61%	6,278 $214,000
Q3 2021 Nov 08, 2021	BUY	$41.66 - $52.52 $280,038 - $353,039	6,722 New	6,722 $324,000
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $281,047 - $342,056	-8,450 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$24.21 - $31.02 $74,082 - $94,921	-3,060 Reduced 26.59%	8,450 $261,000
Q1 2020 May 14, 2020	SELL	$20.5 - $34.53 $17,220 - $29,005	-840 Reduced 6.8%	11,510 $317,000
Q4 2019 Feb 13, 2020	SELL	$18.96 - $29.84 $243,636 - $383,444	-12,850 Reduced 50.99%	12,350 $361,000
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $216,056 - $296,512	-11,300 Reduced 30.96%	25,200 $482,000
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $486,314 - $598,885	24,850 Added 213.3%	36,500 $801,000
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $141,431 - $238,359	11,650 New	11,650 $238,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.83B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.